Erik brings more than 30 years of international pharmaceutical experience spanning product development, commercialization and global product strategy. He has held senior leadership positions at Novo Nordisk, where he played key roles in the successful launch and lifecycle management of several major products.

​

At Zyneyro's board, Erik brings extensive expertise in product strategy, market positioning and value creation, helping guide the Company from innovative science towards successful clinical and commercial development.